Skip to Content
 

News: Home Page Feature

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Health disparity for blacks exists within lung screening guidelines

Saturday, June 29th, 2019

The U.S. Preventive Services Task Force (USPSTF) guidelines that determine which smokers qualify for CT scans exclude significant numbers of African Americans who develop lung cancer, a health disparity that merits modifications to lung cancer screening criteria, according to a study from Vanderbilt researchers.

Vanderbilt surgeons lead nation in study to restore sensation in breast tissue

Friday, June 7th, 2019

Vanderbilt University Medical Center is the nation’s leading recruitment site for a new study examining the effectiveness of donor nerve grafts to restore sensation to breast tissue following mastectomy and reconstruction.

Immunotherapy helping 87-year-old man stay on the job

Friday, June 7th, 2019

Immunotherapy is helping cancer patient Roszell Mack Jr. to continue going to his job on a Kentucky horse farm.

Custom stents saving smiles for some oral cancer patients

Friday, June 7th, 2019

Customized oral stents can minimize harm from radiation therapy for some head and neck cancer patients.

Technology better than tape measure for identifying lymphedema risk

Friday, May 17th, 2019

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.

New guidelines recommend colonoscopy at 45

Thursday, April 25th, 2019

The American Cancer Society now recommends people at average risk be screened for colorectal cancer via colonoscopy, or another method, starting at age 45, rather than at age 50.

VISE team seeks to develop new robot to ease prostatectomies

Thursday, April 25th, 2019

The Vanderbilt Institute for Surgery and Engineering (VISE) team of Robert Webster III, PhD, and Duke Herrell, MD, have received a $2.2 million grant from the National Institutes of Health to develop a new surgical robot for endoscopic transurethral prostatectomy.

Study reframes approach to targeted therapy resistance

Thursday, April 25th, 2019

A recent study provides clinicians genomic guidance for surveillance of targeted therapy resistance in patients with EGFR-mutant non-small cell lung cancer — and more importantly — another drug option when resistance occurs.

Cancer Center’s annual scientific retreat set for May 1

Thursday, April 25th, 2019

The 20th Annual Scientific Retreat will be held Wednesday, May 1, 8:30 a.m. to 3 p.m., at the Vanderbilt University Student Life Center. Registration is free, but attendees should register by April 26. The topic of the retreat is “Signal Transduction in Cancer Initiation, Progression and Treatment.”

Next Page »